Eton Pharmaceuticals Inc

ETONNASDAQ · USD
55.50USD0.00 (-2.76%)
6310

Eton Pharmaceuticals Inc (ETON) Options Open Interest

ETON options open interest is 5,113 contracts. The 2-week average daily volume is 279 contracts across the chain.

Read more

Monitoring ETON open interest helps you see where real money is positioned on Eton Pharmaceuticals Inc's options and which strikes are attracting the most commitment from traders. Eton Pharmaceuticals Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor ETON options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising ETON options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Eton Pharmaceuticals Inc to settle.

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.

It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where ETON open interest is concentrated. Our scanner maps Eton Pharmaceuticals Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Eton Pharmaceuticals Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
50.006.009.307.6574%+0.7361153
65.003.103.10104%+0.342429
70.002.602.60114%+0.281624
60.001.054.202.6371%+0.386213
90.002.252.25164%+0.19792
Puts
50.000.153.101.6366%-0.24745
40.000.700.70100%-0.08894
55.001.954.903.4362%-0.43824
60.005.108.206.6566%-0.62803
45.002.652.65123%-0.21142

As of September 18, 2026

Follow the money

Track ETON open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial